Enterome
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
About
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Their pioneering approach leverages a unique ability to decode the interaction between the gut microbiome and the immune system, using a proprietary Mimicry platform to identify novel therapeutics from a vast database of gut microbiome proteins. The company is advancing pipelines of drug candidates, including OncoMimics™ for cancer and EndoMimics™ for immune diseases.
Key facts
At-a-glance profile data
- Website
- enterome.com
- Headquarters
- Paris, France
- Founded
- 2012
- Employees
- 33
- Total funding
- $124M (Later Stage VC)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 12 Jun 2025 | Later Stage VC | $19M | - |
| 30 Oct 2023 | Accelerator/Incubator | $3M | - |
| 25 Jun 2020 | Series E | $53M | - |
| 1 Jan 2018 | Series D | $39M | - |
| 1 May 2014 | Series B | $11M | Seventure Partners |
Tech stack
Detected on enterome.com, last scanned 18 Sept 2026. Run your own scan
- Frontend
- Bootstrap
- Analytics
- Google Analytics 4, Segment
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
Frequently asked
How much funding has Enterome raised?
Enterome has raised a total of $124M in funding. The most recent round on record is Later Stage VC.
How many employees does Enterome have?
Enterome has approximately 33 people on record.